2019 Q4 Form 10-Q Financial Statement

#000121390019023493 Filed on November 14, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q3
Revenue $340.0K $184.5K $2.083M
YoY Change -84.96% -91.14% 49.31%
Cost Of Revenue $290.0K $366.8K $1.858M
YoY Change -86.45% -80.26% 43.25%
Gross Profit $50.00K -$182.3K $224.8K
YoY Change -58.33% -181.06% 129.67%
Gross Profit Margin 14.71% -98.77% 10.79%
Selling, General & Admin $1.080M $541.7K $690.5K
YoY Change -43.16% -21.54% 81.16%
% of Gross Profit 2160.0% 307.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $40.00K $3.136K $150.0K
YoY Change -75.0% -97.91% 0.0%
% of Gross Profit 80.0% 66.71%
Operating Expenses $1.080M $1.091M $1.302M
YoY Change -42.86% -16.22% 241.7%
Operating Profit -$1.030M -$1.273M -$1.078M
YoY Change -41.81% 18.18% 3.18%
Interest Expense -$180.0K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $10.00K -$52.04K -$960.00
YoY Change 5320.73% -195.71%
Pretax Income -$4.130M -$1.325M -$1.078M
YoY Change 132.02% 22.9% 3.37%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$4.130M -$1.325M -$1.026M
YoY Change 125.68% 29.18% -1.65%
Net Earnings / Revenue -1214.71% -718.31% -49.26%
Basic Earnings Per Share
Diluted Earnings Per Share -$8.787M -$4.750M -$4.905M
COMMON SHARES
Basic Shares Outstanding 6.008M shares 6.008M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.630M $0.00 $2.910M
YoY Change 18.98% -100.0% -52.53%
Cash & Equivalents $1.626M $1.953K $2.913M
Short-Term Investments $0.00
Other Short-Term Assets $17.60M $17.80M $200.0K
YoY Change -81.99% 8800.0% -50.0%
Inventory $0.00
Prepaid Expenses
Receivables $1.101M $1.436M $2.758M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.907M $1.612M $5.981M
YoY Change -33.36% -73.05% -13.19%
LONG-TERM ASSETS
Property, Plant & Equipment $11.75K $12.67K $72.71K
YoY Change -83.53% -82.57% 627.07%
Goodwill $1.224M $4.162M $4.162M
YoY Change -70.6% 0.0%
Intangibles $2.299M $2.335M $2.591M
YoY Change -5.94% -9.88%
Long-Term Investments $10.00K
YoY Change
Other Assets $190.0K
YoY Change
Total Long-Term Assets $3.728M $6.510M $6.833M
YoY Change -44.17% -4.73% -6.91%
TOTAL ASSETS
Total Short-Term Assets $2.907M $1.612M $5.981M
Total Long-Term Assets $3.728M $6.510M $6.833M
Total Assets $6.635M $8.122M $12.81M
YoY Change -39.9% -36.62% -9.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.110M $1.810M $1.990M
YoY Change -19.47% -9.05% 113.98%
Accrued Expenses
YoY Change
Deferred Revenue $169.0K $241.1K
YoY Change -87.34%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.274M $2.049M $4.069M
YoY Change -42.55% -49.66% 135.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.274M $2.049M $4.069M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.274M $2.050M $4.020M
YoY Change -42.56% -49.0% 132.37%
SHAREHOLDERS EQUITY
Retained Earnings -$17.58M -$13.45M -$8.832M
YoY Change 64.9% 52.3%
Common Stock $11.58K $60.08K $42.60K
YoY Change 443.62% 41.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.360M $6.073M $8.745M
YoY Change
Total Liabilities & Shareholders Equity $6.635M $8.122M $12.81M
YoY Change -39.9% -36.62% -9.95%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q3
OPERATING ACTIVITIES
Net Income -$4.130M -$1.325M -$1.026M
YoY Change 125.68% 29.18% -1.65%
Depreciation, Depletion And Amortization $40.00K $3.136K $150.0K
YoY Change -75.0% -97.91% 0.0%
Cash From Operating Activities -$320.0K -$750.0K -$30.00K
YoY Change -79.22% 2400.0% -113.04%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$70.00K
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$10.00K
YoY Change -100.0% -100.0%
Cash From Investing Activities $0.00 $0.00 -$80.00K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.930M 590.0K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -320.0K -750.0K -30.00K
Cash From Investing Activities 0.000 0.000 -80.00K
Cash From Financing Activities 1.930M 590.0K 0.000
Net Change In Cash 1.610M -160.0K -110.0K
YoY Change -204.55% 45.45% -123.91%
FREE CASH FLOW
Cash From Operating Activities -$320.0K -$750.0K -$30.00K
Capital Expenditures $0.00 $0.00 -$70.00K
Free Cash Flow -$320.0K -$750.0K $40.00K
YoY Change -79.08% -1975.0% -82.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Shell Company
EntityShellCompany
false
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
0 USD
CY2019Q3 us-gaap Inventory Net
InventoryNet
0 USD
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
31335 USD
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Inventory Net
InventoryNet
0 USD
CY2019Q3 us-gaap Short Term Investments
ShortTermInvestments
0 USD
dei Entity Central Index Key
EntityCentralIndexKey
0001023994
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
us-gaap Operating Cycle
OperatingCycle
The length of the Company's contracts varies, but is typically between six to twelve months.
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q1 sgbx Options Vested Description
OptionsVestedDescription
These options vest in equal installments over a two-year and three-year period and will fully vest by the end of March 31, 2021.
us-gaap Bankruptcy Proceedings Description Of Proceedings
BankruptcyProceedingsDescriptionOfProceedings
Intangible assets represent the preliminary assets identified upon emergence from bankruptcy and consist of $2,766,000 of proprietary knowledge and technology which is being amortized over 20 years and $1,113,000 of customer contracts which is being amortized over 2.5 years. In addition, included in intangible assets is $ 28,820 of trademarks and $5,300 of website which is being amortized over 5 years.
dei Document Transition Report
DocumentTransitionReport
false
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Entity File Number
EntityFileNumber
001-38037
dei Entity Registrant Name
EntityRegistrantName
SG BLOCKS, INC.
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-4463937
dei Entity Address Address Line1
EntityAddressAddressLine1
195 Montague Street,
dei Entity Address Address Line2
EntityAddressAddressLine2
14<sup>th</sup> Floor,
dei Entity Address City Or Town
EntityAddressCityOrTown
Brooklyn
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11201
dei City Area Code
CityAreaCode
(646)
dei Local Phone Number
LocalPhoneNumber
240-4235
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01
dei Trading Symbol
TradingSymbol
SGBX
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6007791 shares
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1953 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1368395 USD
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1436339 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1746326 USD
CY2019Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
8689 USD
CY2018Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
260325 USD
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
164885 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
986687 USD
CY2019Q3 us-gaap Assets Current
AssetsCurrent
1611866 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
4361733 USD
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12671 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71337 USD
CY2018Q4 us-gaap Goodwill
Goodwill
4162173 USD
CY2019Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2335086 USD
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6007791 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4260041 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4260041 shares
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
60079 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
42601 USD
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19464360 USD
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2443929 USD
CY2019Q3 us-gaap Assets
Assets
8121796 USD
CY2018Q4 us-gaap Assets
Assets
11039172 USD
CY2019Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1807456 USD
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2624218 USD
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
241091 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1334887 USD
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2048547 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3959105 USD
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5405010 shares
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5405010 shares
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6007791 shares
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17700743 USD
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13451190 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10663277 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
6073249 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
7080067 USD
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8121796 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11039172 USD
CY2019Q3 us-gaap Revenues
Revenues
184526 USD
CY2018Q3 us-gaap Revenues
Revenues
2082825 USD
us-gaap Revenues
Revenues
2647558 USD
us-gaap Revenues
Revenues
5932150 USD
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
366783 USD
CY2018Q3 us-gaap Cost Of Revenue
CostOfRevenue
1857985 USD
us-gaap Cost Of Revenue
CostOfRevenue
2018392 USD
us-gaap Cost Of Revenue
CostOfRevenue
5512140 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
-182257 USD
CY2018Q3 us-gaap Gross Profit
GrossProfit
224840 USD
us-gaap Gross Profit
GrossProfit
629166 USD
us-gaap Gross Profit
GrossProfit
420010 USD
CY2019Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
548156 USD
CY2018Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
611906 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1832333 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1589935 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
478726 USD
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
557078 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1318390 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1538441 USD
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.24
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1953 USD
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
63016 USD
CY2018Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
133378 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
194591 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
311965 USD
CY2019Q3 us-gaap Other General Expense
OtherGeneralExpense
1275 USD
CY2018Q3 us-gaap Other General Expense
OtherGeneralExpense
USD
us-gaap Other General Expense
OtherGeneralExpense
19726 USD
us-gaap Other General Expense
OtherGeneralExpense
49964 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
1091173 USD
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
1302362 USD
us-gaap Operating Expenses
OperatingExpenses
3365040 USD
us-gaap Operating Expenses
OperatingExpenses
3490305 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1273430 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1077522 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2735874 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3070295 USD
CY2019Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
USD
CY2018Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
5768 USD
CY2019Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-52039 USD
CY2018Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-52039 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
USD
CY2019Q3 us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
USD
CY2018Q3 us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
-960 USD
us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
USD
us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
-960 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-52039 USD
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-960 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-52039 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4808 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1325469 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1078482 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2787913 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3065487 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-1325469 USD
CY2018Q3 us-gaap Profit Loss
ProfitLoss
-1078482 USD
us-gaap Profit Loss
ProfitLoss
-2787913 USD
us-gaap Profit Loss
ProfitLoss
-3065487 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
USD
CY2018Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-52445 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-52445 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-1325469 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-1026037 USD
us-gaap Net Income Loss
NetIncomeLoss
-2787913 USD
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.56
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.71
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5694748 shares
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4260041 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4938547 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4260041 shares
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
6618322 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
197090 USD
CY2019Q3 sgbx Stock Issued During Period Issuance Of Common Stock Net Of Issuance Costs
StockIssuedDuringPeriodIssuanceOfCommonStockNetOfIssuanceCosts
583306 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
7080067 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
645080 USD
sgbx Stock Issued During Period Issuance Of Common Stock Net Of Issuance Costs
StockIssuedDuringPeriodIssuanceOfCommonStockNetOfIssuanceCosts
1136015 USD
us-gaap Profit Loss
ProfitLoss
-2787913 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-1325469 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
6073249 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
6073249 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
108843 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
442031 USD
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
54000 USD
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
9706183 USD
CY2018Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
117102 USD
CY2018Q3 us-gaap Profit Loss
ProfitLoss
-1078482 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
8744803 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
11527874 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
282416 USD
us-gaap Profit Loss
ProfitLoss
-3065487 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
8744803 USD
us-gaap Profit Loss
ProfitLoss
-2787913 USD
us-gaap Profit Loss
ProfitLoss
-3065487 USD
us-gaap Depreciation
Depreciation
8697 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
4 USD
us-gaap Share Based Compensation
ShareBasedCompensation
482139 USD
us-gaap Share Based Compensation
ShareBasedCompensation
282416 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-52039 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
USD
us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
USD
us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
-960 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-363987 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-247670 USD
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-251636 USD
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
46514 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-821802 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
17922 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-653821 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-160480 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1093796 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
408692 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2500387 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1905411 USD
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
USD
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
30037 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2070 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
69137 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
5000 USD
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
USD
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
7916 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2070 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-52016 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
1136015 USD
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1136015 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1366442 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1957427 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1368395 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4870824 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2913397 USD
us-gaap Stock Issued1
StockIssued1
162941 USD
us-gaap Stock Issued1
StockIssued1
USD
CY2019Q3 us-gaap Other Assets Current
OtherAssetsCurrent
17800000 USD
CY2019Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
17787170 USD
CY2019Q2 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
1136015 USD
CY2019Q2 sgbx Stock Bid Price Per Share
StockBidPricePerShare
1.00
CY2019Q2 sgbx Minimum Threshold For Bid Price
MinimumThresholdForBidPrice
1.00
CY2019Q2 sgbx Stock Bid Price Per Share
StockBidPricePerShare
1.00
CY2019Q2 sgbx Closing Bid Price Per Share
ClosingBidPricePerShare
1.00
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'times new roman', times; font-size: 10pt;"> <div> <div> <div style="border-right: none; border-left: none;"> <div style="border-right: none; border-left: none;"> <div> <div> <p style="margin: 0pt 0pt 0pt 36pt; text-indent: 0pt;"><span style="font-size: 10pt;"><span><b><i>Accounting estimates </i></b>– The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Significant areas that require the Company to make estimates include revenue recognition, stock-based compensation and allowance for doubtful accounts. Actual results could differ from those estimates.</span></span></p> </div> </div> </div> </div> </div> </div> </div>
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
184526 USD
CY2019Q3 sgbx Revenue From Contract With Customer Excluding Assessed Tax Percentage
RevenueFromContractWithCustomerExcludingAssessedTaxPercentage
1 pure
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2082825 USD
CY2018Q3 sgbx Revenue From Contract With Customer Excluding Assessed Tax Percentage
RevenueFromContractWithCustomerExcludingAssessedTaxPercentage
1 pure
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2647558 USD
sgbx Revenue From Contract With Customer Excluding Assessed Tax Percentage
RevenueFromContractWithCustomerExcludingAssessedTaxPercentage
1 pure
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5932150 USD
sgbx Revenue From Contract With Customer Excluding Assessed Tax Percentage
RevenueFromContractWithCustomerExcludingAssessedTaxPercentage
1 pure
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1953 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1368395 USD
CY2018Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1578034 USD
CY2018Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1321604 USD
CY2019Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
36281 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
108843 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
442031 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
36281 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
145124 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
145124 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
140801 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
139007 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1728749 USD
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2335086 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin: 0pt 0pt 0pt 36pt;"><span style="font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-style: italic; font-weight: bold;">Concentrations of credit risk </span><span style="font-family: 'Times New Roman'; font-style: italic;">–</span><span style="font-family: 'Times New Roman';"> Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents. The Company places its cash with high credit quality institutions. At times, such amounts may be in excess of the FDIC insurance limits. The Company has not experienced any losses in its account and believes that it is not exposed to any significant credit risk on the account.</span></span></p> <p style="margin: 0pt; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt;"><span class="ng-scope" style="font-family: 'Times New Roman'; font-size: 10pt;">With respect to receivables, concentrations of credit risk are limited to a few customers in the construction industry. The Company performs ongoing credit evaluations of its customers’ financial condition and, generally, requires no collateral from its customers other than normal lien rights. At <span id="fs_V38HIYKGUO00000000000000000000FM">September 30, 2019</span> and <span id="fs_8NI7HFE94W00000000000000000000fs">December 31, 2018</span>, 92% and <span class="ng-scope" style="border-left: none; border-right: none;">76</span>%, respectively, of the Company’s gross accounts receivable were due from two customers.</span></p> <p style="margin: 0pt; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt;"><span class="ng-scope" style="font-family: 'Times New Roman'; font-size: 10pt;">Revenue relating to two and <span id="fs_HANIMGEZWG00000000000000000000FM">four</span> customers represented approximately 94% and 80% of the Company’s total revenue for the <span id="fs_6VUHV65HU800000000000000000000FM">three months</span> ended <span id="fs_ZCNMH7FIWG00000000000000000000FM">September 30, 2019</span> and <span id="fs_79L71U547K00000000000000000000fs">2018</span>, respectively. <span style="color: #000000; font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">Revenue relating to </span>two<span style="color: #000000; font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"> and </span>one<span style="color: #000000; font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"> customers represented approximately </span>87<span style="color: #000000; font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">% and </span>41<span style="color: #000000; font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">% of the Company’s total revenue for the </span><span id="fs_W3SY0IPGXS00000000000000000000FM">nine months</span><span style="color: #000000; font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"> ended </span>September 30, 2019<span style="color: #000000; font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"> and </span><span id="fs_8DUI4ONDFK00000000000000000000fs">2018</span><span style="color: #000000; font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">, respectively.</span></span></p> <p style="margin: 0pt; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt;"><span style="font-size: 10pt;"><span class="ng-scope" style="font-family: 'Times New Roman';"><span class="ng-scope" style="/* background-color: #ffffff;">Cost of revenue relating to two and four <span style="color: #000000; font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">vendors represented approximately </span>93<span style="color: #000000; font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">% and </span>85<span style="color: #000000; font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">% of the Company’s total cost of revenue for the </span><span id="fs_MQMJKMYLOW00000000000000000000FM">three months</span><span style="color: #000000; font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"> ended </span>September 30, 2019<span style="color: #000000; font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;"> and </span><span id="fs_FGM2OMKX1C00000000000000000000fs">2018</span><span style="color: #000000; font-family: 'Times New Roman'; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important;">, respectively. </span>Cost of revenue relating to four and one </span>vendors represented approximately 94% and 52% of the Company’s total cost of revenue for the <span id="fs_JCTLIXA4OW00000000000000000000FM">nine months</span> ended <span id="fs_I3RVFXOCO000000000000000000000FM">September 30, 2019</span> and <span id="fs_J5R30FT4TS00000000000000000000fs">2018</span>, respectively. The Company believes it has access to alternative suppliers, with limited disruption to the business, should circumstances change with its existing suppliers.</span><span style="font-family: 'Times New Roman';"><br/></span></span></p>
CY2019Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2222234 USD
CY2018Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2586221 USD
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
785895 USD
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
839895 USD
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1436339 USD
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1746326 USD
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
785895 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
54000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
CY2018 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
810580 USD
CY2018 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
4920 USD
CY2019Q3 sgbx Costs Incurred On Uncompleted Contracts
CostsIncurredOnUncompletedContracts
228461 USD
CY2018Q4 sgbx Costs Incurred On Uncompleted Contracts
CostsIncurredOnUncompletedContracts
11307975 USD
CY2019Q3 sgbx Estimated Income Loss On Uncompleted Contracts
EstimatedIncomeLossOnUncompletedContracts
-79852 USD
CY2018Q4 sgbx Estimated Income Loss On Uncompleted Contracts
EstimatedIncomeLossOnUncompletedContracts
-838615 USD
CY2019Q3 us-gaap Contract Receivable Retainage
ContractReceivableRetainage
308313 USD
CY2018Q4 us-gaap Contract Receivable Retainage
ContractReceivableRetainage
12146590 USD
CY2019Q3 sgbx Costs In Excess Of Billings To Date
CostsInExcessOfBillingsToDate
-540715 USD
CY2018Q4 sgbx Costs In Excess Of Billings To Date
CostsInExcessOfBillingsToDate
-13221152 USD
CY2019Q3 sgbx Contract With Customer Asset Liability
ContractWithCustomerAssetLiability
-232402 USD
CY2018Q4 sgbx Contract With Customer Asset Liability
ContractWithCustomerAssetLiability
-1074562 USD
CY2019Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
8689 USD
CY2018Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
260325 USD
CY2019Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
241091 USD
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1334887 USD
CY2019Q3 sgbx Contract With Customer Asset Liability
ContractWithCustomerAssetLiability
-232402 USD
CY2018Q4 sgbx Contract With Customer Asset Liability
ContractWithCustomerAssetLiability
-1074562 USD
CY2019Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20747 USD
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
102672 USD
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8076 USD
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12671 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71337 USD
us-gaap Depreciation
Depreciation
8697 USD
us-gaap Depreciation
Depreciation
3227 USD
CY2017Q3 sgbx Number Of Large Contracts
NumberOfLargeContracts
1 Number
CY2017Q3 sgbx Construction Backlog Contract Revenue
ConstructionBacklogContractRevenue
17000000 USD
CY2018 sgbx Contract Revenue
ContractRevenue
8190712 USD
CY2019Q3 sgbx Construction Contracts Backlog
ConstructionContractsBacklog
17787170 USD
CY2018Q4 sgbx Construction Contracts Backlog
ConstructionContractsBacklog
97657379 USD
CY2018Q4 sgbx Construction Contracts Backlog
ConstructionContractsBacklog
97657379 USD
CY2017Q4 sgbx Construction Contracts Backlog
ConstructionContractsBacklog
76659029 USD
sgbx New Contracts Received During Year
NewContractsReceivedDuringYear
17474684 USD
CY2018 sgbx New Contracts Received During Year
NewContractsReceivedDuringYear
58805877 USD
sgbx Adjustments And Cancellations Net
AdjustmentsAndCancellationsNet
94697335 USD
CY2018 sgbx Adjustments And Cancellations Net
AdjustmentsAndCancellationsNet
29616815 USD
sgbx Construction Backlog Gross
ConstructionBacklogGross
20434728 USD
CY2018 sgbx Construction Backlog Gross
ConstructionBacklogGross
105848091 USD
sgbx Contract Revenue
ContractRevenue
2647558 USD
CY2019Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
17787170 USD
CY2019Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
17787170 USD
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
142777 USD
CY2018Q3 us-gaap Share Based Compensation
ShareBasedCompensation
117102 USD
us-gaap Share Based Compensation
ShareBasedCompensation
482139 USD
us-gaap Share Based Compensation
ShareBasedCompensation
282416 USD
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
142777 USD
CY2018Q3 us-gaap Share Based Compensation
ShareBasedCompensation
117102 USD
us-gaap Share Based Compensation
ShareBasedCompensation
482139 USD
us-gaap Share Based Compensation
ShareBasedCompensation
282416 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
40098 USD
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
117102 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
112293 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
282416 USD
CY2019Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
51619 USD
CY2019Q3 us-gaap Share Price
SharePrice
0.42
CY2018Q1 sgbx Number Of Employees
NumberOfEmployees
6 Employee
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
320000 USD

Files In Submission

Name View Source Status
0001213900-19-023493-index-headers.html Edgar Link pending
0001213900-19-023493-index.html Edgar Link pending
0001213900-19-023493.txt Edgar Link pending
0001213900-19-023493-xbrl.zip Edgar Link pending
ex101_1.htm Edgar Link pending
ex311_2.htm Edgar Link pending
ex312_3.htm Edgar Link pending
ex321_4.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sgbx-20190930.htm Edgar Link pending
sgbx-20190930.xsd Edgar Link pending
sgbx-20190930_cal.xml Edgar Link unprocessable
sgbx-20190930_def.xml Edgar Link unprocessable
sgbx-20190930_htm.xml Edgar Link completed
sgbx-20190930_lab.xml Edgar Link unprocessable
sgbx-20190930_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending